Association of glutathione-S-transferase gene polymorphism and lipoprotein subclasses in hemodialysis patients

Clinical Biochemistry

Volumn 47, Issue 6, 2014, Pages 398-403

  Vekic, Jelena ^a   Zeljkovic, Aleksandra ^a   Jelic Ivanovic, Zorana ^a   Damjanovic, Tatjana ^b   Suvakov, Sonja ^a   Matic, Marija ^a   Savic Radojevic, Ana ^a   Simic, Tatjana ^a   Spasojevic Kalimanovska, Vesna ^a   Gojkovic, Tamara ^a   Spasic, Slavica ^a   Dimkovic, Nada ^a,b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

Author keywords

Cardiovascular disease risk; Dense LDL; End stage renal disease; Glutathione S transferase polymorphism; HDL subclasses; Small

Indexed keywords

GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 2B; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN 3A; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE P1; LIPOPROTEIN;

ADULT; ARTICLE; DISEASE ASSOCIATION; DNA POLYMORPHISM; END STAGE RENAL DISEASE; FEMALE; GENE DELETION; GENOTYPE; HEMODIALYSIS PATIENT; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING; CLASSIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; RENAL REPLACEMENT THERAPY;

FEMALE; GENETIC ASSOCIATION STUDIES; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RENAL DIALYSIS; SMOKING;

EID: 84897112913     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.11.011     Document Type: Article

References (38)

1. Weiner D.E., Tighiouart H., Elsayed E.F., Griffith J.L., Salem DN D.N., Levey A.S., et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol 2007, 50:217-224.
2. Rizzo M., Berneis K., Zeljkovic A., Vekic J. Should we routinely measure low-density and high-density lipoprotein subclasses. Clin Lab 2009, 55:421-429.
3. Vekic J., Zeljkovic A., Bogavac-Stanojevic N., Jelic-Ivanovic Z., Spasojevic-Kalimanovska V., Simic-Ogrizovic S., et al. Cox proportional hazard model analysis of survival in end-stage renal disease patients with small-sized high-density lipoprotein particles. Clin Biochem 2011, 44:635-641.
4. Zeljkovic A., Vekic J., Spasojevic-Kalimanovska V., Jelic-Ivanovic Z., Peco-Antic A., Kostic M., et al. Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients. Transpl Int 2011, 24:1094-1102.
5. Wilce M., Parker M. Structure and function of glutathione S-transferase. Biochim Biophys Acta 1994, 1205:1-18.
6. Strange R.C., Jones P.W., Fryer A.A. Glutathione S-transferase: genetics and role in toxicology. Toxicol Lett 2000, 112-113:357-363.
7. Simic T., Savic-Radojevic A., Pljesa-Ercegovac M., Matic M., Mimic-Oka J. Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol 2009, 6:281-289.
8. Suvakov S., Damjanovic T., Stefanovic A., Pekmezovic T., Savic-Radojevic A., Pljesa-Ercegovac M., et al. Glutathione S-transferase A1, M1, P1 and T1 null or low-activity genotypes are associated with enhanced oxidative damage among haemodialysis patients. Nephrol Dial Transplant 2013, 28:202-212.
9. Nomani H., Mozafari H., Ghobadloo S.M., Rahimi Z., Raygani A.V., Rahimi M.A., et al. The association between GSTT1, M1, and P1 polymorphisms with coronary artery disease in Western Iran. Mol Cell Biochem 2011, 354:181-187.
10. Ramprasath T., Senthil Murugan P., Prabakaran A.D., Gomathi P., Rathinavel A., Selvam G.S. Potential risk modifications of GSTT1, GSTM1 and GSTP1 (glutathione-S-transferases) variants and their association to CAD in patients with type-2 diabetes. Biochem Biophys Res Commun 2011, 407:49-53.
11. Wilson M., Grant P., Hardie L., Wild C. Glutathione-S-transferase M1-null genotype is associated with a decreased risk of myocardial infarction. FASEB J 2000, 14:791-796.
12. Wang L.S., Tang J.J., Tang N.P., Wang M.W., Yan J.J., Wang Q.M., et al. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking. Clin Chem Lab Med 2008, 46:1720-1725.
13. Masetti S., Botto N., Manfredi S., Colombo M.G., Riza A., Vassalle C. Interactive effect of the glutathione-S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med 2003, 81:488-494.
14. Rizzo M., Kotur-Stevuljevic J., Berneis K., Spinas G., Rini G.B., Jelic-Ivanovic Z., et al. Atherogenic dyslipidemia and oxidative stress: a new look. Transl Res 2009, 153:217-223.
15. Vekic J., Kotur-Stevuljevic J., Jelic-Ivanovic Z., Spasic S., Spasojevic-Kalimanovska V., Topic A., et al. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. Eur J Clin Invest 2007, 37:715-723.
16. Libetta C., Sepe V., Esposito P., Galli F., Dal Canton A. Oxidative stress and inflammation: implications in uremia and hemodialysis. Clin Biochem 2011, 44:1189-1198.
17. Rainwater D.L., Moore P.H., Gamboa I.O. Improved method for making nondenaturing composite gradient gels for the electrophoretic separation of lipoproteins. J Lipid Res 2004, 45:773-775.
18. Vekic J., Topic A., Zeljkovic A., Jelic-Ivanovic Z., Spasojevic-Kalimanovska V. LDL and HDL subclasses and their relationship with Framingham risk score in middle-aged Serbian population. Clin Biochem 2007, 40:310-316.
19. Zeljkovic A., Vekic J., Spasojevic-Kalimanovska V., Jelic-Ivanovic Z., Bogavac-Stanojevic N., Gulan B., et al. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis 2010, 210:548-554.
20. Zeljkovic A., Spasojevic-Kalimanovska V., Vekic J., Jelic-Ivanovic Z., Topic A., Bogavac-Stanojevic M., et al. Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?. Clin Exp Med 2008, 8:109-116.
21. Abdel-Rahman S.Z., el-Zein R.A., Anwar W.A., Au W.W. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996, 107:229-233.
22. Harries L.W., Stubbins M.J., Forman D., Howard G.C., Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997, 18:641-644.
23. Tsompanidi E.M., Brinkmeier M.S., Fotiadou E.H., Giakoumi S.M., Kypreos K.E. HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis 2010, 208:3-9.
24. Tsimihodimos V., Mitrogianni Z., Elisaf M. Dyslipidemia associated with chronic kidney disease. Open Cardiovasc Med J 2011, 5:41-48.
25. Reiman I., Harper L., McPake D., Kendall M.J., Wheeler D.C. Low-density lipoprotein subfraction profiles in chronic renal failure. Nephrol Dial Transplant 1998, 13:2281-2287.
26. Wang J., Zou L., Huang S., Lu F., Lang X., Han L., et al. Genetic polymorphisms of glutathione S-transferase genes GSTM1, GSTT1 and risk of coronary heart disease. Mutagenesis 2010, 25:365-369.
27. Lin Y.S., Hung S.C., Wei Y.H., Tarng D.C. GST M1 polymorphism associates with DNA õoxidative damage and mortality among hemodialysis patients. J Am Soc Nephrol 2009, 20:405-415.
28. Ceballos-Picot I., Witko-Sarsat V., Merad-Boudia M., Nguyen A.T., Thévenin M., Jaudon M.C., et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med 1996, 21:845-853.
29. Kim S.J., Kim M.G., Kim K.S., Song J.S., Yim S.V., Chung J.H. Impact of glutathione S-transferase M1 and T1 gene polymorphisms on the smoking-related coronary artery disease. J Korean Med Sci 2008, 23:365-372.
30. Chelland Campbell S., Moffatt R.J., Stamford B.A. Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 2008, 201:225-235.
31. Yarnell J.W. Smoking and cardiovascular disease. QJM 1996, 89:493-498.
32. Gepner A.D., Piper M.E., Johnson H.M., Fiore M.C., Baker T.B., Stein J.H. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J 2011, 161:145-151.
33. Datta S.K., Kumar V., Pathak R., Tripathi A.K., Ahmed R.S., Kalra O.P., et al. Association of glutathione S transferase M1 and T1 gene polymorphism with oxidative stress in diabetic and nondiabetic chronic kidney disease. Ren Fail 2010, 32:1189-1195.
34. Yang Y., Kao M.T., Chang C.C., Chung S.Y., Chen C.M., Tsai J.J., et al. Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int J Mol Med 2004, 14:855-859.
35. Coombes J.S., Fassett R.G. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int 2012, 81:233-246.
36. Abdollahzad H., Eghtesadi S., Nourmohammadi I., Khadem-Ansari M., Nejad-Gashti H., Esmaillzadeh A. Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients. Int J Vitam Nutr Res 2009, 79:281-287.
37. Brown B.G., Zhao X.Q., Chait A., Fisher L.D., Cheung M.C., Morse J.S., et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001, 345:1583-1592.
38. Nikolic D., Nikfar S., Salari P., Rizzo M., Ray K.K., Pencina M.J., et al. Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trials. Curr Med Res Opin 2013, 29:435-451.